In the summer of 2015, a time when China’s pharmaceutical market was in a phase of rapid expansion, a sudden…
Read More »PharmCube
Chinese drug maker 3SBio has licensed its new cancer drug to US pharmaceutical giant Pfizer in the largest deal ever…
Read More »
Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to invest in Chinese healthcare start-ups, as…
Read More »